Nonalcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risk: Is Imaging Helpful?
Publication/Presentation Date
1-1-2024
Abstract
Nonalcoholic Fatty Liver Disease (NAFLD) is proving to be a globally prevalent condition. Moreover, NAFLD may be an independent risk factor associated with higher cardiovascular (CVD) morbidity and mortality. Further studies are needed to assess whether NAFLD needs to be included in the atherosclerotic risk score algorithms or whether patients with NAFLD need to be screened early on to assess their CVD risk especially since imaging such as positron emission tomography can be used to assess both NAFLD and CV disease at the same time. Therefore employing cardiovascular imaging modalities to investigate the incidence, extent, and nature of atherosclerotic lesions in NAFLD may be beneficial. Additionally, whether treating NAFLD halts the progression of CVD on imaging remains to be seen. Further research to delineate NAFLD and CVD associations, deciphering screening imaging modalities, and investigating targeted interventions could improve CVD morbidity and mortality in NAFLD.
Volume
49
Issue
1 Pt B
First Page
102065
Last Page
102065
ISSN
1535-6280
Published In/Presented At
Doumas, S. A., Tripathi, S., Kashikar, A., Khuttan, A., Kumar, A., Singh, H., Canakis, J. P., Ashish, K., Dey, D., Oppenheim, I., & Dey, A. K. (2024). Nonalcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risk: Is Imaging Helpful?. Current problems in cardiology, 49(1 Pt B), 102065. https://doi.org/10.1016/j.cpcardiol.2023.102065
Disciplines
Medicine and Health Sciences
PubMedID
37652112
Department(s)
Fellows and Residents
Document Type
Article